You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Zalcitabine - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for zalcitabine and what is the scope of patent protection?

Zalcitabine is the generic ingredient in one branded drug marketed by Roche and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for zalcitabine
Recent Clinical Trials for zalcitabine

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
AvexaPhase 3
National Institute of Allergy and Infectious Diseases (NIAID)Phase 2/Phase 3
PENTA FoundationPhase 2/Phase 3

See all zalcitabine clinical trials

Medical Subject Heading (MeSH) Categories for zalcitabine

US Patents and Regulatory Information for zalcitabine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche HIVID zalcitabine TABLET;ORAL 020199-001 Jun 19, 1992 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Roche HIVID zalcitabine TABLET;ORAL 020199-002 Jun 19, 1992 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for zalcitabine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche HIVID zalcitabine TABLET;ORAL 020199-001 Jun 19, 1992 ⤷  Try a Trial ⤷  Try a Trial
Roche HIVID zalcitabine TABLET;ORAL 020199-001 Jun 19, 1992 ⤷  Try a Trial ⤷  Try a Trial
Roche HIVID zalcitabine TABLET;ORAL 020199-002 Jun 19, 1992 ⤷  Try a Trial ⤷  Try a Trial
Roche HIVID zalcitabine TABLET;ORAL 020199-002 Jun 19, 1992 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.